"Designing Growth Strategies is in our DNA"

Oncology Drugs Market Size, Share & Industry Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI103431

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Cancer,  By Region/Country, 2023
    2. Overview of Different Oncology Drugs With Respect to Regulatory Approvals and Clinical Trials
    3. Pricing Analysis, Key Brands / Key Players, 2023
    4. Key Industry Development (Mergers, Acquisitions and Partnerships)
    5. Impact of COVID-19 on the Market
  5. Global Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
        1. By Drug Class
      2. Canada
        1. By Drug Class
  7. Europe Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K
        1. By Drug Class
      2. Germany
        1. By Drug Class
      3. France
        1. By Drug Class
      4. Spain
        1. By Drug Class
      5. Italy
        1. By Drug Class
      6. Scandinavia
        1. By Drug Class
      7. Rest of Europe
        1. By Drug Class
  8. Asia Pacific Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
        1. By Drug Class
      2. China
        1. By Drug Class
      3. India
        1. By Drug Class
      4. Australia
        1. By Drug Class
      5. Southeast Asia
        1. By Drug Class
      6. Rest of Asia Pacific
        1. By Drug Class
  9. Latin America Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
        1. By Drug Class
      2. Mexico
        1. By Drug Class
      3. Rest of Latin America
        1. By Drug Class
  10. Middle East & Africa Oncology Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC
        1. By Drug Class
      2. South Africa
        1. By Drug Class
      3. Rest of Middle East & Africa
        1. By Drug Class
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. AbbVie, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Bristol Myers Squibb Company
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. GlaxoSmithKline plc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Eli Lilly and Company
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. AstraZeneca
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Sanofi
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Bayer AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Merck & Co., Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Oncology Drugs Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Oncology Drugs Market Value Share (%), by Drug Class, 2023 & 2032

Figure 3: Global Oncology Drugs Market Value Share (%), by Therapy, 2023 & 2032

Figure 4: Global Oncology Drugs Market Value Share (%), by Indication, 2023 & 2032

Figure 5: Global Oncology Drugs Market Value Share (%), by Dosage Form, 2023 & 2032

Figure 6: Global Oncology Drugs Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 7: Global Oncology Drugs Market Value (USD billion), by Region, 2023 & 2032

Figure 8: North America Oncology Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 9: North America Oncology Drugs Market Value Share (%), by Drug Class, 2023

Figure 10: North America Oncology Drugs Market Value (USD billion), by Therapy, 2023 & 2032

Figure 11: North America Oncology Drugs Market Value Share (%), by Therapy, 2023

Figure 12: North America Oncology Drugs Market Value (USD billion), by Indication, 2023 & 2032

Figure 13: North America Oncology Drugs Market Value Share (%), by Indication, 2023

Figure 14: North America Oncology Drugs Market Value (USD billion), by Dosage Form, 2023 & 2032

Figure 15: North America Oncology Drugs Market Value Share (%), by Dosage Form, 2023

Figure 16: North America Oncology Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 17: North America Oncology Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 18: North America Oncology Drugs Market Value (USD billion), By Country, 2023 & 2032

Figure 19: North America Oncology Drugs Market Value Share (%), By Country, 2023

Figure 20: Europe Oncology Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 21: Europe Oncology Drugs Market Value Share (%), by Drug Class, 2023

Figure 22: Europe Oncology Drugs Market Value (USD billion), by Therapy, 2023 & 2032

Figure 23: Europe Oncology Drugs Market Value Share (%), by Therapy, 2023

Figure 24: Europe Oncology Drugs Market Value (USD billion), by Indication, 2023 & 2032

Figure 25: Europe Oncology Drugs Market Value Share (%), by Indication, 2023

Figure 26: Europe Oncology Drugs Market Value (USD billion), by Dosage Form, 2023 & 2032

Figure 27: Europe Oncology Drugs Market Value Share (%), by Dosage Form, 2023

Figure 28: Europe Oncology Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 29: Europe Oncology Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 30: Europe Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 31: Europe Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 32: Asia Pacific Oncology Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 33: Asia Pacific Oncology Drugs Market Value Share (%), by Drug Class, 2023

Figure 34: Asia Pacific Oncology Drugs Market Value (USD billion), by Therapy, 2023 & 2032

Figure 35: Asia Pacific Oncology Drugs Market Value Share (%), by Therapy, 2023

Figure 36: Asia Pacific Oncology Drugs Market Value (USD billion), by Indication, 2023 & 2032

Figure 37: Asia Pacific Oncology Drugs Market Value Share (%), by Indication, 2023

Figure 38: Asia Pacific Oncology Drugs Market Value (USD billion), by Dosage Form, 2023 & 2032

Figure 39: Asia Pacific Oncology Drugs Market Value Share (%), by Dosage Form, 2023

Figure 40: Asia Pacific Oncology Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 41: Asia Pacific Oncology Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 42: Asia Pacific Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 43: Asia Pacific Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 44: Latin America Oncology Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 45: Latin America Oncology Drugs Market Value Share (%), by Drug Class, 2023

Figure 46: Latin America Oncology Drugs Market Value (USD billion), by Therapy, 2023 & 2032

Figure 47: Latin America Oncology Drugs Market Value Share (%), by Therapy, 2023

Figure 48: Latin America Oncology Drugs Market Value (USD billion), by Indication, 2023 & 2032

Figure 49: Latin America Oncology Drugs Market Value Share (%), by Indication, 2023

Figure 50: Latin America Oncology Drugs Market Value (USD billion), by Dosage Form, 2023 & 2032

Figure 51: Latin America Oncology Drugs Market Value Share (%), by Dosage Form, 2023

Figure 52: Latin America Oncology Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 53: Latin America Oncology Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 54: Latin America Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 55: Latin America Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 56: Middle East & Africa Oncology Drugs Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 57: Middle East & Africa Oncology Drugs Market Value Share (%), by Drug Class, 2023

Figure 58: Middle East & Africa Oncology Drugs Market Value (USD billion), by Therapy, 2023 & 2032

Figure 59: Middle East & Africa Oncology Drugs Market Value Share (%), by Therapy, 2023

Figure 60: Middle East & Africa Oncology Drugs Market Value (USD billion), by Indication, 2023 & 2032

Figure 61: Middle East & Africa Oncology Drugs Market Value Share (%), by Indication, 2023

Figure 62: Middle East & Africa Oncology Drugs Market Value (USD billion), by Dosage Form, 2023 & 2032

Figure 63: Middle East & Africa Oncology Drugs Market Value Share (%), by Dosage Form, 2023

Figure 64: Middle East & Africa Oncology Drugs Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 65: Middle East & Africa Oncology Drugs Market Value Share (%), by Distribution Channel, 2023

Figure 66: Middle East & Africa Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 67: Middle East & Africa Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2023

Figure 68: Global Oncology Drugs Market Share (%), By Company, 2023

Table 1: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 2: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 3: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 4: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019–2032

Table 5: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 6: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019–2032

Table 7: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2032

Table 8: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2032

Table 9: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 10: Global Oncology Drugs Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 11: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 12: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 13: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 14: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2032

Table 15: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 16: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2032

Table 17: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2032

Table 18: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2032

Table 19: North America Oncology Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 20: North America Oncology Drugs Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 21: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 22: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 23: U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 24: Canada Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 25: Canada Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 26: Canada Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 27: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 28: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 29: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 30: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2032

Table 31: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 32: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2032

Table 33: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2032

Table 34: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2032

Table 35: Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 36: Europe Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 37: U.K. Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 38: U.K. Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 39: U.K. Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 40: Germany Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 41: Germany Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 42: Germany Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 43: France Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 44: France Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 45: France Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 46: Italy Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 47: Italy Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 48: Italy Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 49: Spain Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 50: Spain Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 51: Spain Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 52: Scandinavia Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 53: Scandinavia Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 54: Scandinavia Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 55: Rest of Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 56: Rest of Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 57: Rest of Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 58: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 59: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 60: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 61: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2032

Table 62: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 63: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2032

Table 64: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2032

Table 65: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2032

Table 66: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 67: Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 68: China Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 69: China Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 70: China Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 71: India Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 72: India Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 73: India Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 74: Japan Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 75: Japan Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 76: Japan Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 77: Australia Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 78: Australia Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 79: Australia Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 80: Southeast Asia Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 81: Southeast Asia Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 82: Southeast Asia Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 83: Rest of Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 84: Rest of Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 85: Rest of Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 86: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 87: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 88: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 89: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2032

Table 90: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 91: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2032

Table 92: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2032

Table 93: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2032

Table 94: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 95: Latin America Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 96: Brazil Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 97: Brazil Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 98: Brazil Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 99: Mexico Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 100: Mexico Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 101: Mexico Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 102: Rest of Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 103: Rest of Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 104: Rest of Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 105: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 106: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 107: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 108: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2032

Table 109: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 110: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2032

Table 111: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2032

Table 112: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2032

Table 113: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 114: Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 115: GCC Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 116: GCC Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 117: GCC Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 118: South Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 119: South Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 120: South Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Table 121: Rest of Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 122: Rest of Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2032

Table 123: Rest of Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2032

Oncology Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 190
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase